Effect of HDL and apoAI on PGE2 production by monocyte-derived macrophages

Xiaoqin Zhou , Eckardstein von Arnold

Current Medical Science ›› 2002, Vol. 22 ›› Issue (4) : 270 -272.

PDF
Current Medical Science ›› 2002, Vol. 22 ›› Issue (4) : 270 -272. DOI: 10.1007/BF02896760
Article

Effect of HDL and apoAI on PGE2 production by monocyte-derived macrophages

Author information +
History +
PDF

Abstract

Effect of antiatherogenic high density lipoprotein (HDL) and apolipoprotein AI (apoAI) on production of prostaglandin E2(PGE2) by human monocyte-derived macrophages was investigated. Macrophages were loaded with acetylated low density lipoprotein followed by incubation with HDL3 or apoAI. PGE2 produced and secreted in culture supernatant was quantified by enzyme immunoassay. HDL3 induced production of PGE2 by macrophages in a time-dependent manner. 24 h after incubation, PGE2 production by HDL3-treated macrophages increased 3. 7-fold of that by control cells. ApoAI also induced PGE2 secretion to 2. 1-fold, which was significantly less than HDL3. The data indicate that both HDL3 and lipid-free apoAI enhance PGE2 synthesis and secretion by human macrophages and this may further contribute to the protection from atherosclerosis.

Keywords

prostaglandin E2 / high density lipoprotein / macrophage / monocyte-derived / apolipoprotein AI / atherosclerosis

Cite this article

Download citation ▾
Xiaoqin Zhou, Eckardstein von Arnold. Effect of HDL and apoAI on PGE2 production by monocyte-derived macrophages. Current Medical Science, 2002, 22(4): 270-272 DOI:10.1007/BF02896760

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AssmannG, CullenP, JossaF, et al. . Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. Arterioscler Thromb Vasc Biol, 1999, 19: 1819-1819

[2]

KamS. Woo, PingC, OlliT. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol, 1999, 19: 2487-2487

[3]

MillerG J, MillerN E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet, 1975, 1: 16-16

[4]

BasuS K, GoldsteinJ L, AndersonG W, et al. . Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA, 1976, 73: 3178-3178

[5]

SchmitzG, FischerH, BeuckM, et al. . Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages. Arteriosclerosis, 1990, 10: 1010-1010

[6]

HajjarD P, PomerantzK B. Signal transduction in atherosclerosis: integration of cytokines and the e-icosanoid network. FASEB J, 1992, 6: 2933-2933

[7]

MorisakiN, KanzakiT, KitaharaM, et al. . Inhibitory effect of prostaglandin E2 on cholesterol ester accumulation in macrophages. Biochem Biophys Res Commun, 1986, 137: 461-461

[8]

SubbiahM T. Prostaglandin E2 biosynthesis and effect in pigeon aorta. Possible role in atherogenesis. Atherosclerosis, 1978, 29: 487-487

[9]

FitzsimmonsC, ProudfootD, BowyerD E, et al. . Monocyte prostaglandins inhibit procollagen secretion by human vascular smooth muscle cells: implications for plaque stability. Atherosclerosis, 1999, 142: 287-287

[10]

JambouD, DejourN, BayerP, et al. . Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis. Biochim Biophys Acta, 1993, 1168: 115-115

[11]

FleisherL N, TallA R, WitteL D, et al. . Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem, 1982, 257: 6653-6653

[12]

PomerantzK B, TallA R, FeinmarkS J, et al. . Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins. Circ Res, 1984, 54: 554-554

AI Summary AI Mindmap
PDF

98

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/